Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.
暂无分享,去创建一个
A. Gazdar | S. Bates | A. Fojo | L. Mickley | D. Loriaux | H. Dichek | C. Shieh | Susan E. Bates | A. Gazdar | D. Loriaux | C. Shieh | HELÉN L. Dichek
[1] T. Triche,et al. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. , 1990, Cancer research.
[2] S. Bates,et al. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. , 1989, The Journal of biological chemistry.
[3] S. Horwitz,et al. Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. , 1989, The Journal of biological chemistry.
[4] Robert,et al. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. , 1989, The Journal of biological chemistry.
[5] N. Samaan,et al. Adrenal cortical carcinoma. , 1987, Cancer.
[6] V. Ling,et al. Mechanism of multidrug resistance. , 1988, Biochimica et biophysica acta.
[7] M. Schlumberger,et al. 5‐Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma , 1988, Cancer.
[8] I. Pastan,et al. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. , 1988, Molecular pharmacology.
[9] I. Pastan,et al. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. , 1987, The Journal of biological chemistry.
[10] M. Inouye,et al. Use of GC/MS/SIM for rapid determination of plasma levels of o,p'-DDD, o,p'-DDE and o,p'-DDA. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[11] I. Pastan,et al. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Israel,et al. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. , 1987, Cancer research.
[14] E. S. Hunter,et al. Expression of rat transforming growth factor alpha mRNA during development occurs predominantly in the maternal decidua , 1987, Molecular and cellular biology.
[15] A. Safa,et al. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. , 1987, The Journal of biological chemistry.
[16] G. Åkerström,et al. Treatment of hormone‐producing adrenocortical cancer with o,p'DDD and streptozocin , 1987, Cancer.
[17] I. Pastan,et al. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. , 1987, The Journal of biological chemistry.
[18] I. Pastan,et al. Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Housman,et al. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.
[20] I. Pastan,et al. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. , 1986, The Journal of biological chemistry.
[21] I. Pastan,et al. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[22] I. Pastan,et al. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. , 1986, Science.
[23] Y. Kuratomi,et al. Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. , 1986, Journal of the National Cancer Institute.
[24] J. Riordan,et al. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines , 1985, Nature.
[25] S. Horwitz,et al. A phosphoglycoprotein associated with taxol resistance in J774.2 cells. , 1985, Cancer research.
[26] I. Pastan,et al. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. , 1985, Cancer research.
[27] I. Pastan,et al. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs , 1985, Somatic cell and molecular genetics.
[28] T. Tsuruo,et al. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. , 1984, Cancer research.
[29] D. Melton,et al. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.
[30] H. V. van Slooten,et al. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring. , 1984, European journal of cancer & clinical oncology.
[31] W. T. Beck,et al. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts. , 1983, Molecular pharmacology.
[32] N. Samaan,et al. Adrenal cortical carcinoma a study of 77 cases , 1983, Cancer.
[33] H. vanSlooten,et al. CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma. , 1983 .
[34] T. Tsuruo,et al. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. , 1982, Cancer research.
[35] W. T. Beck,et al. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. , 1979, Cancer research.
[36] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[37] M. Roginsky,et al. Metastatic adrenal cortical carcinoma. Documented cure with combined chemotherapy. , 1975, Archives of internal medicine.
[38] V. Ling,et al. Reduced permeability in CHO cells as a mechanism of resistance to colchicine , 1974, Journal of cellular physiology.
[39] L. Freeman,et al. Mitotane use in inoperable adrenal cortical carcinoma. , 1973, JAMA.
[40] J. L. Biedler,et al. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. , 1970, Cancer research.
[41] A. Hutter,et al. Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients. , 1966, The American journal of medicine.
[42] M. Lipsett,et al. CHEMOTHERAPY OF ADRENOCORTICAL CANCER WITH o,p′DDD , 1960 .